1. Ola MS, Nawaz MI, Siddiquei MM. . Recent advances in un-derstanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complications. 2012; 26:56–64.
Article
2. Frank RN.Etiologic mechanisms in diabetic retinopathy. Ryan SJ, Retina Schachat AP., editors4th ed.Los Angeles: Mosby;2006. v. 2. chap. 66.
3. Yoon JH, Kim MJ, Chin HS, Moon YS.Effect of PRP on visual acuity, visual field and subjective symptoms in very severe NPDR. J Korean Ophthalmol Soc. 2003; 44:2545–52.
4. Lee BH, Cho YW.Quantitative analysis of diabetic macular edema by optical coherence tomography. J Korean Ophthalmol Soc. 2004; 45:1858–64.
5. Ito H, Horii T, Nishijima K. . Association between fluorescein leakage and optical coherence tomographic characteristics of mi-croaneurysms in diabetic retinopathy. Retina. 2013; 33:732–9.
Article
6. Hood DC.Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000; 19:607–46.
Article
7. Sutter EE, Dodsworth-Feldman B, Haegerstrom-Portnoy G.Simultaneous multifocal ERGs in diseased retina. Invest Ophthalmol Vis Sci. 1986; 27:301–2.
8. Lung JC, Swann PG, Wong DS, Chan HH.Global flash multifocal electroretinogram: early detection of local functional changes and its correlations with optical coherence tomography and visual field tests in diabetic eyes. Doc Ophthalmol. 2012; 125:123–35.
Article
9. Hood DC, Zhang X.Multifocal ERG and VEP responses and visu-al fields: comparing disease-related changes. Doc Ophthalmol. 2000; 100(2-3):115–37.
10. Hood DC, Bach M, Brigell M. et al. International Society For Clinical Electrophysiology of Vision. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol. 2012; 124:1–13.
11. Harris A, Bingaman D, Ciulla TA, Martin B.Retinal and choroidal blood flow in health and disease. Ryan SJ, Schachat AP, editors. Retina. 4th ed.Los Angeles: Mosby;2006. v. 1:chap. 5.
Article
12. Hood DC, Frishman LJ, Saszik S, Viswanathan S.Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci. 2002; 43:1673–85.
13. Hood DC, Greenstein V, Frishman L. . Identifying inner retinal contributions to the human multifocal ERG. Vision Res. 1999; 39:2285–91.
Article
14. Miller RF.The physiology and morphology of the vertebrate retina. Ryan SJ, Schachat AP, editors. Retina. 4th ed.Los Angeles: Mosby;2006. v. 1:chap. 9.
Article
15. Kim SJ, Yu HG.The clinical applications of multifocal electro-retinogram in diabetic retinopathy. J Korean Ophthalmol Soc. 2004; 45:64–8.
16. Kondo M, Miyake Y, Horiguchi M. . Clinical evaluation of multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1995; 36:2146–50.
17. Fine BS, Brucker AJ.Macular edema and cystoid macular edema. Am J Ophthalmol. 1981; 92:466–81.
Article
18. Roth JA.Central visual field in diabetes. Br J Ophthalmol. 1969; 53:16–25.
Article
19. Bengtsson B, Heijl A, Agardh E.Visual fields correlate better than visual acuity to severity of diabetic retinopathy. Diabetologia. 2005; 48:2494–500.
Article
20. Federman JL, Lloyd J.Automated static perimetry to evaluate dia-betic retinopathy. Trans Am Ophthalmol Soc. 1984; 82:358–70.
21. Pahor D.Automated static perimetry as a screening method for evaluation of retinal perfusion in diabetic retinopathy. Int Ophthalmol. 1997-1998; 21:305–9.
22. Greenstein VC, Holopigian K, Hood DC. . The nature and ex-tent of retinal dysfunction associated with diabetic macular edema. Invest Ophthalmol Vis Sci. 2000; 41:3643–54.